Protagenic Therapeutics, Inc. (PTIXW)

USD 0.01

(-42.86%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 28.21 Thousand 30.00 - 286.00 339.00 347.00
Gross Profit -28.21 Thousand -30.00 - -286.00 -339.00 -347.00
Operating Expenses 4.52 Million 3.55 Million 4.14 Million 2.55 Million 2.08 Million 2.31 Million
Selling, General and Administrative Expenses 1.2 Million 1.96 Million 3 Million 1.85 Million 1.27 Million 1.43 Million
Research and Development Expenses 3.31 Million 1.58 Million 1.13 Million 699.79 Thousand 807.94 Thousand 881.18 Thousand
Other Expenses - - - - - -
Cost and Expenses 4.52 Million 3.55 Million 4.14 Million 2.55 Million 2.08 Million 2.31 Million
Operating Income -4.52 Million -3.55 Million -4.14 Million -2.55 Million -2.08 Million -2.31 Million
Interest Expense - 137.45 Thousand 496.91 Thousand 246.17 Thousand 15.88 Thousand 2790.00
Income Tax Expense - 46.05 Thousand 463.7 Thousand 246.17 Thousand 15.88 Thousand 486.8 Thousand
Earnings before Tax -5 Million -3.55 Million -4.52 Million -2.54 Million -1.75 Million -2.55 Million
Net Income -5 Million -3.6 Million -4.98 Million -2.79 Million -1.76 Million -2.55 Million
Earnings Per Share Basic -1.15 -0.83 -1.35 -1.08 -0.69 -1.00
Earnings Per Share Diluted -1.15 -0.83 -1.35 -1.08 -0.69 -1.00
Weighted Average Shares Outstanding 4.34 Million 4.31 Million 3.68 Million 2.58 Million 2.56 Million 2.56 Million
Weighted Average Shares Outstanding (Diluted) 4.34 Million 4.31 Million 3.68 Million 2.58 Million 2.56 Million 2.56 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -4.49 Million -3.41 Million -4.14 Million -2.55 Million -2.08 Million -2.31 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts